Form 4: Harvard Bioscience CEO Sells Shares to Cover Tax Obligations After RSU Vesting

Harvard Bioscience CEO James W. Green disposed of shares to cover tax obligations following the vesting of restricted stock units.

Summary

• James W. Green, CEO of Harvard Bioscience, sold a total of 82,225 shares of common stock on December 29, 2024.
• The sales were executed at a price of $1.98 per share.
• These transactions were to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
• Following these transactions, Mr. Green still beneficially owns 3,028,866 shares of common stock.
• This includes 117,713 RSUs vesting on December 29, 2025, 214,797 RSUs vesting in three equal installments on March 19, 2025, 2026 and 2027, 699,772 RSUs with performance based vesting conditions and 1,996,584 shares of common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across various industries.
• The amount of shares sold is typical for RSU vesting events for a CEO of a company of this size.
• The price of $1.98 per share is the market price at the time of the transaction.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a routine sale by an executive to cover tax obligations.
• The sale does not indicate any change in the executive's confidence in the company.

Key Dates

Keywords

Harvard Bioscience, James W. Green, CEO, stock sale, restricted stock units, RSU, tax obligations, insider trading, share disposal